The role of activated adenosine receptors in degranulation of human LAD2 mast cells

Purinergic Signalling

Volumn 10, Issue 3, 2014, Pages 465-475

  Leung, Chi Ting ^a   Li, Ang ^a,b   Banerjee, Juni ^a   Gao, Zhan Guo ^c   Kambayashi, Taku ^a   Jacobson, Kenneth A ^c   Civan, Mortimer M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

A2A; A2B; A3; ATP release; C3a; Fc RI

Indexed keywords

9-CHLORO-2-(2-FURYL)-(1,2,4)TRIAZOLO(1,5-C)QUINAZOLIN-5-IMINE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; QUINAZOLINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DRUG EFFECTS; HUMAN; MAST CELL; METABOLISM; MOUSE;

ANIMALS; CELL LINE; HUMANS; MAST CELLS; MICE; MICE, INBRED BALB C; PURINERGIC P1 RECEPTOR ANTAGONISTS; QUINAZOLINES; RECEPTORS, PURINERGIC P1; TRIAZOLES;

EID: 84894633583     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-014-9409-4     Document Type: Article

References (48)

1. Prussin C, Metcalfe DD (2006) IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 117(2 Suppl Mini-Primer):S450–S456
2. Irani AM (2008) Ocular mast cells and mediators. Immunol Allergy Clin North Am 28(1):25–42, v
3. Turner H, Kinet JP (1999) Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature 402(6760 Suppl):B24–B30
4. Duffy SM, Cruse G, Brightling CE, Bradding P (2007) Adenosine closes the K + channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor. Eur J Immunol 37(6):1653–1662
5. Broide DH (2001) Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol 108(2 Suppl):S65–S71
6. Gilfillan AM, Tkaczyk C (2006) Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 6(3):218–230
7. Venkatesha RT, Berla Thangam E, Zaidi AK, Ali H (2005) Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol Immunol 42(5):581–587
8. Marquardt DL, Parker CW, Sullivan TJ (1978) Potentiation of mast cell mediator release by adenosine. J Immunol 120(3):871–878
9. van den Berge M, Hylkema MN, Versluis M, Postma DS (2007) Role of adenosine receptors in the treatment of asthma and chronic obstructive pulmonary disease: recent developments. Drugs R D 8(1):13–23
10. Yip KH, Lau HY, Wise H (2011) Reciprocal modulation of anti-IgE induced histamine release from human mast cells by A(1) and A(2B) adenosine receptors. Br J Pharmacol 164(2b):807–819
11. Yip KH, Wong LL, Lau HY (2009) Adenosine: roles of different receptor subtypes in mediating histamine release from human and rodent mast cells. Inflamm Res 58(Suppl 1):17–19
12. Broide DH, Metcalfe DD, Wasserman SI (1988) Functional and biochemical characterization of rat bone marrow derived mast cells. J Immunol 141(12):4298–4305
13. Gomez G, Zhao W, Schwartz LB (2011) Disparity in FcepsilonRI-induced degranulation of primary human lung and skin mast cells exposed to adenosine. J Clin Immunol 31 (3):479–487
14. Peachell PT, Lichtenstein LM, Schleimer RP (1991) Differential regulation of human basophil and lung mast cell function by adenosine. J Pharmacol Exp Ther 256(2):717–726
15. Zaidi AK, Amrani Y, Panettieri RA, Ali H (2006) Response to C3a, mast cells, and asthma. Faseb J 20(2):199
16. Hua X, Chason KD, Jania C, Acosta T, Ledent C, Tilley S (2013) Gs-coupled adenosine receptors differentially limit antigen-induced mast cell activation. J Pharmacol Exp Ther 344(2):426–435
17. Hua X, Chason KD, Fredholm BB, Deshpande DA, Penn RB, Tilley SL (2008) Adenosine induces airway hyperresponsiveness through activation of A3 receptors on mast cells. J Allergy Clin Immunol 122 (1):107–113, 113 e101-107
18. Hua X, Kovarova M, Chason KD, Nguyen M, Koller BH, Tilley SL (2007) Enhanced mast cell activation in mice deficient in the A2b adenosine receptor. J Exp Med 204(1):117–128
19. Auchampach JA, Jin X, Wan TC, Caughey GH, Linden J (1997) Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. Mol Pharmacol 52(5):846–860
20. Suzuki H, Takei M, Nakahata T, Fukamachi H (1998) Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of Fc epsilon RI. Biochem Biophys Res Commun 242(3):697–702
21. Osipchuk Y, Cahalan M (1992) Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature 359(6392):241–244
22. Marquardt DL, Gruber HE, Wasserman SI (1984) Adenosine release from stimulated mast cells. Proc Natl Acad Sci U S A 81(19):6192–6196
23. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, Rao VK, Metcalfe DD (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 27(8):677–682
24. Kambayashi T, Okumura M, Baker RG, Hsu CJ, Baumgart T, Zhang W, Koretzky GA Independent and cooperative roles of adaptor molecules in proximal signaling during FcepsilonRI-mediated mast cell activation. Mol Cell Biol 30(17)
25. Li A, Leung CT, Peterson-Yantorno K, Mitchell CH, Civan MM (2010) Pathways for ATP release by bovine ciliary epithelial cells, the initial step in purinergic regulation of aqueous humor inflow. Am J Physiol Cell Physiol 299(6):C1308–C1317
26. Kim HO, Ji XD, Siddiqi SM, Olah ME, Stiles GL, Jacobson KA (1994) 2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors. J Med Chem 37(21):3614–3621
27. Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nature Rev 5:1–18
28. Kecskes M, Kumar TS, Yoo L, Gao ZG, Jacobson KA (2010) Novel Alexa Fluor-488 labeled antagonist of the A(2A) adenosine receptor: Application to a fluorescence polarization-based receptor binding assay. Biochem Pharmacol 80(4):506–511
29. Kim YC, Ji X, Melman N, Linden J, Jacobson KA (2000) Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors. J Med Chem 43(6):1165–1172
30. Liang BT, Haltiwanger B (1995) Adenosine A2a and A2b receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation. Circ Res 76(2):242–251
31. Li A, Leung CT, Peterson-Yantorno K, Stamer WD, Civan MM (2011) Cytoskeletal dependence of adenosine triphosphate release by human trabecular meshwork cells. Invest Ophthalmol Vis Sci 52(11):7996–8005
32. Li A, Banerjee J, Peterson-Yantorno K, Stamer WD, Leung CT, Civan MM (2012) Effects of cardiotonic steroids on trabecular meshwork cells: search for mediator of ouabain-enhanced outflow facility. Exp Eye Res 96(1):4–12
33. Li A, Leung CT, Peterson-Yantorno K, Stamer WD, Mitchell CH, Civan MM (2012) Mechanisms of ATP release by human trabecular meshwork cells, the enabling step in purinergic regulation of aqueous humor outflow. J Cell Physiol 227:172–182
34. Möller C, Xiang Z, Nilsson G (2003) Activation of mast cells by immunoglobulin E-receptor cross-linkage, but not through adenosine receptors, induces A1 expression and promotes survival. Clin Exp Allergy 33(8):1135–1140
35. Marquardt DL, Walker LL, Heinemann S (1994) Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. J Immunol 152(9):4508–4515
36. Reeves JJ, Jones CA, Sheehan MJ, Vardey CJ, Whelan CJ (1997) Adenosine A3 receptors promote degranulation of rat mast cells both in vitro and in vivo. Inflamm Res 46(5):180–184
37. Hua X, Chason KD, Patel JY, Naselsky WC, Tilley SL (2011) IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors. PLoS One 6(9):e24947
38. Forsythe P, McGarvey LP, Heaney LG, MacMahon J, Ennis M (1999) Adenosine induces histamine release from human bronchoalveolar lavage mast cells. Clin Sci (Lond) 96(4):349–355
39. Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MA, Muskens F, Hoogsteden HC, Luttmann W, Ferrari D, Di Virgilio F, Virchow JC Jr, Lambrecht BN (2007) Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nature Medicine 13(8):913–919
40. Livingston M, Heaney LG, Ennis M (2004) Adenosine, inflammation and asthma–a review. Inflamm Res 53(5):171–178
41. Hughes PJ, Holgate ST, Church MK (1984) Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem Pharmacol 33(23):3847–3852
42. Zhong H, Chunn JL, Volmer JB, Fozard JR, Blackburn MR (2001) Adenosine-mediated mast cell degranulation in adenosine deaminase-deficient mice. J Pharmacol Exp Ther 298(2):433–440
43. Driver AG, Kukoly CA, Ali S, Mustafa SJ (1993) Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148(1):91–97
44. Shin Y, Daly JW, Jacobson KA (1996) Activation of phosphoinositide breakdown and elevation of intracellular calcium in a rat RBL-2H3 mast cell line by adenosine analogs: involvement of A(3)-adenosine receptors? Drug Dev Res 39(1):36–46
45. Fredholm BB, Irenius E, Kull B, Schulte G (2001) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 61(4):443–448
46. Epperson SA, Brunton LL, Ramirez-Sanchez I, Villarreal F (2009) Adenosine receptors and second messenger signaling pathways in rat cardiac fibroblasts. Am J Physiol Cell Physiol 296(5):C1171–C1177
47. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53(4):527–552
48. Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Müller CE, International Union of Basic and Clinical Pharmacology (2011) Nomenclature and classification of adenosine receptors—an update. Pharmacol Rev 63(1):1–34